lncRNA Validation: Knockout vs Knockdown vs Antisense Oligonucleotides

For protein-coding genes, knockout and knockdown are largely interchangeable: both reduce the product, and the difference matters mainly for kinetics. For lncRNAs, they are not interchangeable, because a lncRNA locus contains three potentially functional things — the DNA sequence, the act of transcription, and the RNA transcript — and different tools remove different subsets.

So the decision procedure is: decide which of the three you are claiming, then choose the tool that isolates it. Efficiency comparisons come second.

The second and fourth columns are the ones that decide the study. A knockout phenotype plus an ASO phenotype with the same direction is evidence for the RNA; a knockout-only phenotype points to DNA or transcription.

Two practical notes that decide many projects: siRNA performs poorly on nuclear lncRNAs, and ASOs require attention to uptake — gymnosis efficiency varies by cell type, so a failed ASO experiment often reflects delivery rather than biology.

"This locus is required for the phenotype." Knockout, with two independent clones and sequenced breakpoints. The locus-level claim is the only one a deletion supports cleanly.

"The transcript is required." ASO with two independent oligos, verified depletion in the correct compartment, plus a rescue with an ASO-resistant transcript. The rescue is what makes the claim about the RNA rather than the locus.

"Transcription through this region is required." CRISPRi at the promoter, or polyA insertion. Both leave the DNA in place; disagreement between them and the knockout is informative.

"The RNA acts in the cytoplasm." siRNA is acceptable and cheaper; complement with polysome or imaging readouts to establish localization.

"We want to screen many candidates." CRISPRi or ASO, depending on throughput: CRISPRi scales in pooled format, ASO scales in arrayed format.

The most informative design uses two tools that differ in what they remove:

• • Knockout plus ASO. If both reduce the phenotype, the RNA is implicated. If only the knockout works, the DNA or transcription is.
• • CRISPRi plus ASO. If CRISPRi works and ASO does not, the effect is likely transcriptional or chromatin-mediated rather than post-transcriptional.
• • Knockout plus rescue. Re-expressing the transcript from a heterologous locus restores the phenotype only if the RNA is the functional unit.

In practice, a two-tool design costs little more than a single-tool design and pre-empts the most common reviewer objection in lncRNA papers — that the phenotype was never attributable to the transcript.

The third row is the load-bearing one for ASO work, and the fifth for CRISPRi work.

The last row is a reminder that "knockdown worked" should be a compartment-specific statement.

Four questions account for most lncRNA revision requests, and each maps to a specific experiment:

The first question is the one that determines whether the study is about an RNA at all. Studies that answer only the second and third tend to be published as locus-level findings, which is a legitimate but narrower claim.

A useful planning heuristic: if the project can afford only two perturbations, choose the pair whose disagreement is most informative — usually knockout plus ASO. If it can afford three, add a rescue, which converts an association into an attribution.

EDITGENE builds matched lncRNA perturbation sets: knockout clones with sequenced breakpoints, CRISPRi lines, polyA-insertion lines, and ASO-validated transcript depletion with compartment fractionation and rescue derivatives.

Tell us the locus and the claim you need to support. Contact EDITGENE to request a project consultation or quote.

Tool performance varies with cell type, transcript abundance, localization, and delivery method; the comparisons here describe what each tool can support rather than expected efficiency.

Attribution of a phenotype to an RNA requires a perturbation that leaves DNA and transcription intact, plus rescue; locus-level claims should be reported as such.

• • Statello L, et al. Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology. 2021;22:96–118.
• • Engreitz JM, et al. Local regulation of gene expression by lncRNA promoters, transcription and splicing. Nature. 2016;539:452–455.
• • Liu SJ, et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. 2017;355:eaah7111.
• • Crooke ST, et al. Antisense technology: an overview and prospectus. Nature Reviews Drug Discovery. 2021;20:427–453.